Cannabis Law Report

APRIL 12, 2019

I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3% Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

United Patients Group

MAY 17, 2023

Cannabinoids can promote sleep by activating receptors in the brain called endocannabinoid receptors CB1R and CB2R that regulate sleep cycles, pain perception, immune responses and moods such as depression. They can also promote sleep by activating receptors in the brain that regulate circadian rhythm (the biological clock).

Sleep 81

Sleep Cannabinoids Patients CBD 81

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Less well-known symptoms include sleep disorders , cognitive changes, pain, anxiety, depression , and hallucinations. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

JULY 23, 2021

According to a New Frontier Data Report, the overall legal cannabis industry in America is valued at roughly $13.2 We will be expanding production in sync with how the patient population grows, and we will continue to offer the broadest product selection for our patients and continue to innovate as well,” said Ruark.

Tincture 105

Tincture Patients Sleep Retail 105

SpeedWeed

AUGUST 22, 2021

A report released by the MS Society states that not nearly enough medical cannabis patients have been able to obtain medical cannabis through the National Health Service (NHS), despite research and firsthand accounts of its effectiveness as a medicine for MS patients. deserves access to effective?treatments.” treatments.” .

Sleep 52

Sleep Access Patients Treatment 52

Veriheal

AUGUST 15, 2022

People who suffer from fatigue may struggle with physical exertion, weight fluctuation, depression, emotional imbalance, and sleeping disturbances. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. The sessions were logged by a total of 1,224 people who had access to the app.

Treatment 96

Treatment Research and Development Sativa Cannabinoids 96

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. People using illicit products were more likely to be treating mental health or sleep conditions.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

The Joint Blog

DECEMBER 12, 2019

For the study researchers “included data from people in 2 prospective cohorts. The most commonly reported therapeutic reasons for cannabis use were pain (36%), sleep (35%), stress (31%), and nausea (30%).” However, there is a lack of research using individual-level data to explore this question. Methods and findings.

Chronic Pain 49

Chronic Pain Patients Data Sleep 49

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

The Cannigma

MARCH 14, 2023

And the truth was that many of the early medical cannabis patients were severely ill. And states like California that left it up to a patient and their doctor to decide whether cannabis was appropriate for them were accused of using medical cannabis as a guise for full legalization.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

OCTOBER 18, 2021

This is an exciting opportunity for Canntab, as we believe 36Eight’s unique and valuable complementary platform will support our ability to provide effective solutions for patients while reinforcing the confidence of patients in their relationship with their clinical pharmacist,” said Larry Latowsky , CEO of Canntab.

Data 52

Data Research and Development Patients Cannabinoids 52

Veriheal

NOVEMBER 8, 2022

However, another stereotype-smashing study found that cannabis legalization is tied to lower obesity rates as more citizens and patients take to cannabis consumption. The researchers used obesity data in Washington State between 2002-2018 because it is one of the first states to have legalized recreational or adult-use cannabis.

Research and Development 98

Research and Development Consumption Recreational Food 98

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. I never thought that would have been possible,” he said. However, the results were ultimately inconsistent. Gregory Rec/Staff Photographer.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

SEPTEMBER 14, 2021

Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. “By Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Veriheal

MAY 3, 2022

Kevin Potter taking responsibility for the integrity and accuracy of the data. a necessary question to address as medical marijuana becomes more accessible. The study also said that the participants could continue their usual treatments or psychiatric care but did not specify which conditions the patients had.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

The Cannigma

AUGUST 24, 2021

Encouraging purposeful cannabis consumption is the stated goal of Jointly, a smart phone app devoted to helping cannabis fans and patients find the most reliable, safest, and effective cannabis products for them, so they can achieve their wellness goals. Best app for medical marijuana patients – PotBot. Learn More.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

In reality, people using marijuana during this time may have been self-medicating for a mental condition, choosing to use a different coping mechanism than the pharmaceuticals available at the time, pursuing better sleep, or simply enjoying a nontraditional method of increasing productivity and creativity. Eades, J., & Hogue, O.

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results. The methods for both phases were the same.

Safety 52

Safety Hemp Research and Development Data 52

SpeedWeed

MARCH 11, 2021

A new study recently published in the Journal of Adolescent Health collected data on 14,798 adolescents aged 12 to 17 who vaped weed or tobacco between December 2016 and January 2018. Teens who vaped pot were more likely to have their sleep, speech, or exercise disturbed by wheezing, and were also more likely to have dry coughing at night.

Vaping 52

Vaping Sleep History Collective 52

Greencamp

AUGUST 16, 2018

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results. The methods for both phases were the same.

Safety 52

Safety Hemp Research and Development Data 52

CannaMD

DECEMBER 9, 2020

Noting that the effects of oral administration of cannabis (edibles) can be less predictable that smoked or vaporized administration of products with similar levels of specific cannabinoids, the AHA cautions: Patients must be made aware that the onset of effects begins within 30 minutes to ?1 for men, 1.3%

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

DECEMBER 14, 2021

The products launched under its flagship medical Ceed brand and are comprised of four formulations that will be available for patients throughout the UK when prescribed by a specialist consultant. Columbia Care’s mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Info

MARCH 2, 2019

Epilepsy is usually diagnosed after patients have experienced a series of seizures. However, the most common attempt at treating the condition is through medication, many patients may need to take them for the rest of their life. ” CBD may be easier for patients to access when they opt to start treatment with medical cannabis.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

The Cannigma

MARCH 25, 2021

My partner, who was diagnosed with Crohn’s Disease at the age of 19, was able to improve his quality of life with cannabis by managing his nausea, poor quality sleep, gut motility, appetite, pain, and anxiety with a single substance. I also advocated alongside my partner for many years as part of the patient group United Patients Alliance.

Patients 145

Patients Clinical Trials Medicine Events 145

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

OCTOBER 3, 2022

On top of recognizing the vast scope of benefits cannabis can provide, patients are saving lots of hard-earned money by swapping their pills for cannabis. The team that conducted the study looked at stock return and prescription drug sales data for 556 pharmaceutical companies. Why Patients Are Choosing MMJ Over Pharmaceuticals.

Pharmaceutical 104

Pharmaceutical Patients Research and Development Legalization 104

The Cannigma

JUNE 21, 2021

Certain sleep patterns in teens are associated with increased odds of cannabis use and binge drinking behavior the following year, claims new research from the University of Pittsburgh School of Medicine. Preference for sleeping late at night was associated with a greater likelihood of cannabis use the following year. Shutterstock).

Sleep 61

Sleep Data Patients Chronic Pain 61

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

SEPTEMBER 23, 2021

Note: Veriheal does not support illegally consuming therapeutic substances such as Iboga but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies. Main Takeaway.

Treatment 98

Treatment Medicine Research and Development Therapy 98

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Healer

NOVEMBER 15, 2023

Let’s start by taking a look at the new data and what it means. First, it’s important to point out that I usually wait until new data makes its way through the scientific peer-review process and is published in a journal before giving it much time and energy. During that time, 2,958 (1.9%) developed heart failure.

Data 126

Data Topical Research and Development Conditions 126

Veriheal

AUGUST 31, 2021

His device not only provides an accessible option for cannabis users who are moving away from smoking but also opens up the opportunity for unique experiences with cannabis in the same way Starbucks revolutionized how people drink coffee. . Essay Summary: Camille is a registered nurse working towards a career as a Family Nurse Practitioner.

Research and Development 116

Research and Development Supply Chain Programs Education 116

The Cannigma

JANUARY 13, 2023

The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally. A 2019 retrospective review of 316 patients found that medical cannabis improved the experience of 88.3%

Terpenes 132

Terpenes Strains THC Treatment 132

SpeedWeed

JULY 19, 2021

On June 23, Canada’s cannabis regulatory agency, Health Canada, released a private document requested under the Access to Information Act (AIA), that country’s version of the US government’s Freedom of Information Act. The data contained in that report has rocked the cannabis vaping world. The data was far worse than he imagined.

Vaping 52

Vaping Terpenes Data Research and Development 52